NR3C1 and Alzheimer disease: The loss of the neutrophin-mediated pathway aggravated the harmful effects of the brain cortisol response, which the authors suggested may contribute to the onset or progression of AD, making drugs that specifically increase GR phosphorylation at neurotrophic sites an important target for therapeutic intervention [40].